When it comes to beauty formulations that are inclusive of people and planet, finding a middle ground is not always easy. Natural ingredients often rely on farming practices that often require a lot ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Biotechnology is relevant today for any enterprise that employs people (who seek to be healthier), delivers products (that need to be more efficient and effective) or is geographically located on ...

Our Food & Beverage and FDA teams explore a plan from a trio of federal agencies that seeks to implement regulatory reform and update the Coordinated Framework for the Regulation of Biotechnology. The ...

The global biotechnology market was valued at USD 1.55 trillion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030, reaching USD 3.88 trillion by 2030 ...

LONDON (Reuters) - The world's six biggest-selling drugs in 2014 will all be biotech products, underlining the importance of the sector for the global pharmaceuticals industry, according to an ...

The Invesco Biotechnology & Genome ETF (PBE) was launched on June 23, 2005, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the ...

At the end of 2025, as part of a bundle of measures to make the EU health sector more innovative, competitive and resilient, the European Commission proposed the EU Biotech Act (the Act) aimed at ...

In trading on Monday, biotechnology shares were relative laggards, down on the day by about 3%. Helping drag down the group were shares of Quince Therapeutics, down about 16.2% and shares of Kalaris ...